SCHEMBL17204992

SCHEMBL17204992

CCOC(=O)c1c(O)cc(Cc2ccsc2)[nH]c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 2/20 0.44
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
ADORA2B P29275 3/20 0.41
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP3A4 P08684 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
USP2 O75604 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.40
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20095078 0.81 KDM4E (0.58) KDM4EALDH1A1NR1H2NR1H3MAPT
SCHEMBL1061985 0.78 KDM4E (0.72) KDM4EALDH1A1NR1H2NR1H3MAPT
SCHEMBL17204366 0.77 ALOX5 (0.58) KDM4EALDH1A1MEN1MAPTKMT2A
SCHEMBL17204571 0.77 KDM4E (0.53) KDM4EALDH1A1NR1H2NR1H3KMT2A
SCHEMBL1061682 0.76 KDM4E (0.68) KDM4EALDH1A1NR1H2NR1H3MAPT
SCHEMBL1062838 0.72 KDM4E (1.00) KDM4EALDH1A1NR1H2NR1H3MAPT
SCHEMBL7901087 0.71 CYP3A4 (0.58) KDM4ENR1H2NR1H3MEN1MAPT
SCHEMBL20095236 0.68 PDE3B (0.55) KDM4EALDH1A1MAPTALOX5LMNA
SCHEMBL46291 0.68 PDE5A (0.50) ALDH1A1MEN1MAPTKMT2AHSD17B10
SCHEMBL4511837 0.68 PDE5A (0.50) KDM4EALDH1A1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111620870-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2023-01-03 CN disclosed
CN-111620870-A Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-09-04 CN disclosed
CN-106414445-B Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells 蒙特利尔大学 2020-07-03 CN disclosed
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells Universitéde Montréal (CA) 2020-05-12 US disclosed
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells Universitéde Montréal (CA) 2020-05-12 US disclosed
EP-3134409-B1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIV MONTREAL (CA) 2020-02-12 EP disclosed
EP-3134409-B1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIV MONTREAL (CA) 2020-02-12 EP disclosed
EP-3134409-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2017-03-01 EP disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS UNIVERSITE DE MONTREAL (CA) 2017-02-09 US disclosed
WO-2015161373-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2015-10-29 WO disclosed
WO-2015161373-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS Université de Montréal (CA) 2015-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647718-B2 Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells HPGDS, HCLS1, THPO KDM4E 1764/4885ALDH1A1 19/4885NR1H2 1993/4885
US-20170037047-A1 COMPOUNDS AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS AND/OR HEMATOPOIETIC PROGENITOR CELLS HPGDS, HCLS1, THPO KDM4E 1764/4885ALDH1A1 19/4885NR1H2 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.